Home › Markets › Health Care › BOLT

Bolt Biotherapeutics Inc. (BOLT)

BOLT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$4.29
+1.06% on the day
Market cap
$8.3M
Nano cap
Revenue · 2025
$7.7M
+0.1% on 2024
Net income · 2025
-$33.4M
-433.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerBOLT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001641281
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$7.7M
Net income-$33.4M
Operating income-$36.1M
Net margin-433.7%
Operating margin-469.3%
Revenue growth+0.1%
Cash$11.7M
Total assets$56.7M
P/E (computed)Net income was not positive
P/S (computed)1.1×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52022-04-07
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-08-11
Latest current report8-K2026-10-06
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 291 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
IMRNImmuron Limited$1.040.00%$8.4M
ADILAdial Pharmaceuticals Inc$3.29-6.00%$8.6M
CNSPCNS Pharmaceuticals Inc.$5.35+3.08%$7.8M
TCRTAlaunos Therapeutics Inc.$3.03+188.57%$7.7M
MBRXMoleculin Biotech Inc.$0.4352+5.15%$8.9M
CURXCuranex Pharmaceuticals Inc$4.880.00%$7.7M
CALCCalciMedica Inc.$1.12-7.05%$7.6M
CMMBChemomab Therapeutics Ltd. American Depositary Share$1.24-10.79%$9.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier